Font Size:
a
A
A
Keyword [SREBP]
Result: 1 - 20 | Page: 1 of 10
1.
Role Of Methionine Metabolism Abnormity In Pathogenic Mechanism Of Progression Of Alcoholic Fatty Liver Diseases
2.
Study On The Role Of NPC1 On SREBP Pathway In Cellular Cholesterol Metabolism
3.
Mechanism Of The Treatment Effect Of Resveratrol On The High-fat Induced Insulin Resistance And Hepatic Lipotoxicity
4.
Studenties On Cerebrovascular Diseases By SNPs Of SREBP And Fas/FasL Genes And Dynamics Of Serum Level
5.
Research Of Protective Effects And Mechanisms Of Polydatin On Nonalcoholic Fatty Liver Disease
6.
The Impact Of HepG2.2.15 Cell Steatosis On HBV Degeneration And SOCS-3 And SREBP-1c Pathway
7.
Mouse PNPLA3 Influences Systemic Lipid And Glucose Homeostasis
8.
Fenofibrate And Pioglitazone On Liver Fat Deposition And Insulin Resistance Study Of The Mechanism Of Action
9.
Curcumin Molecular Mechanism Of Hepatocyte Ldlr Expression Study
10.
Studies Of Expression And Role Of ATP Citrate Lyase In Epithelial Ovarian Cancer
11.
Effects Of Tanshinone ⅡA On Sebaceous Gland Hyperplasia Of Golden Hamsters And Its Inhibition Of HaCaT Cell Lipid Synthesis Pathway
12.
Mechanism Study On Insulin Resistance And Therapy In High-Fat-Fed Rats
13.
The MRNA Expression Of SREBP-1c,CYP4A10,CYP4A14 And CYP2E1 In Rat With Nonalcoholic Fatty Liver Disease
14.
The Study Of The SREBPs
15.
Foam Cells Derived From Macrophages By Chol: MβCD And The Effect Of Ezetimibe On It
16.
Effect Of Curcumin On Cholesterol Cumulation And Its Relationship With SREBP-1 Activity In VSMCs
17.
The Role And Mechanism Of The Fatty Acid Metabolism Disorders Mediated By LXRα And SREBP-1c In The Development Of NAFLD In Rats
18.
Activation Of Liver X Receptors (LXRs) Upregulates Fatty Acid Synthase (FAS) Expression In Liver
19.
SOCS-3 Expression In The Liver Of NAFLD Rat Model And The Intervention Study Of Rosiglitazone
20.
Study On Fatty Liver Disease Of Macroangiopathy In Rat Model Of Type 2 Diabetes Mellitus And The Effect Of Rosiglitazone Interence
<<First
<Prev
Next>
Last>>
Jump to
